Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy-Reference-Cited by-同舟云学术

Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy

Published:2019-01-01 Issue:1 Volume:26 Page:34-44
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zong Zhenkun¹²³,Hua Lei¹²³,Wang Zhen²,Xu Haoyue²,Ye Chengkun²,Pan Bomin²,Zhao Zongren²,Zhang Longzhen⁴,Lu Jun⁵,Liu Hongmei²³⁶,Yu Rutong¹²³⁶

Affiliation:

1. Nanjing Medical University, Nanjing, China;

2. Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China;

3. Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;

4. Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;

5. Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, China;

6. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

China Postdoctoral Science Foundation funded project

Jiangsu Province, Key Research & Development Plan of Jiangsu Province

Jiangsu provincial Commission of Health and Family Planning

Jiangsu Provincial Medical Youth Talent

Xuzhou Municipal Bureau of Science and Technology

Postgraduate Research & Practice Innovation Program of Jiangsu Province

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2018.1534897

Reference39 articles.

1. Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug

2. Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process

3. PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery

4. Temozolomide in the treatment of recurrent malignant glioma

5. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma;Molecular Oncology;2024-09-14

2. Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma;The Kaohsiung Journal of Medical Sciences;2024-03-14

3. Surface Functionalized Lipid Nanoparticles in Promoting Therapeutic Outcomes: An Insight View of the Dynamic Drug Delivery System;Current Drug Targets;2024-03

4. Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma;Chemical Engineering Journal;2023-10

5. Interactions of Nanoscale Self-Assembled Peptide-Based Assemblies with Glioblastoma Cell Models and Spheroids;ACS Omega;2023-03-22